Triple threat: new combo aims to tackle breast cancer brain metastases
Disease control
Ongoing
This study tests a three-part approach for people with breast cancer that has spread to the brain. First, they receive focused radiation (stereotactic radiosurgery) along with a drug called olaparib, which may make cancer cells more sensitive to radiation. After that, they get an…
Phase: PHASE1, PHASE2 • Sponsor: Colette Shen • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC